Press Release: New Advisory Group for Medical Marketing Professionals in the Life Science Industry

Skila on Twitter

Press Release

New Advisory Group for Medical Marketing Professionals in the Life Science Industry

Morris Plains, NJ, March 24, 2009 – Skila and Mr. Michael Schaffer are proud to announce the creation of a unique Linked-In group; “The Medical Marketing Group.” The purpose of The Medical Marketing Group is to set industry-first medical marketing policies and guidelines and bring medical marketing professionals together in a forum designed to address the most important issues they face today. Group membership is for those who specialize in medical marketing in the pharmaceutical, medical device and biotech industries. The group will tackle issues impacting medical marketing and cover such diverse topics as KOL Development, Peer-to-Peer physician mapping, and trends in the health care industry being driven at government levels – such as the Obama presidency. In order to initiate this dialog between medical marketing professionals, Skila and Mr. Schaffer will be introducing an upcoming webinar focused on changing government regulations and their effect on the medical marketing community. This webinar will be the first series for group members.

Unique aspects of this group will also include an upcoming dedicated and interactive web site, www.themedicalmarketinggroup.com, and periodic face-to-face industry-supported medical marketing advisory meetings. Additional webinars will also be offered on a quarterly basis, offering members exclusive perspectives from industry leaders and peers from around the world speaking on relevant medical marketing topics.

To find out more about The Medical Marketing Group and the upcoming webinar, please contact, Sara Melo-Pereira.

About Skila

Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.

BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.

To receive more information:

Do You Skila?